Lapatinib Ditosylate Monohydrate CAS 388082-78-8 Tsafta>99.0% (HPLC)

Takaitaccen Bayani:

Sunan Chemical: Lapatinib Ditosylate Monohydrate

Saukewa: 388082-78

Tsafta:> 99.0% (HPLC)

Bayyanar: Kodadde Yellow zuwa Yellow Crystalline Foda

Tuntuɓi: Dr. Alvin Huang

Wayar hannu/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Lapatinib Intermediates:

Abubuwan Sinadarai:

Sunan Sinadari Lapatinib Ditosylate Monohydrate
Makamantu N-[3-chloro-4-[(3-fluorophenyl) methoxy] phenyl]-6-[5-[(2-methylsulfonylethylamino) methyl]furan-2-yl] quinazolin-4-amine
Lambar CAS 388082-78-8
Matsayin Hannun jari A Stock
Tsarin kwayoyin halitta C29H26ClFN4O4S·2(C7H8O3S)·H2O
Nauyin Kwayoyin Halitta 943.48
COA & MSDS Akwai
Asalin Shanghai, China
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Kodadde Rawaya zuwa Yellow Crystalline Foda
Tsarkake / Hanyar Bincike ≥99.0% (HPLC)
Matsayin narkewa 240.0 ~ 242.0 ℃
Danshi (KF) 1.9 ~ 2.4%
Tsaftace Guda Daya ≤0.50%
Jimlar ƙazanta ≤1.00%
Karfe masu nauyi (kamar Pb) ≤20ppm
Matsayin Gwaji Matsayin Kasuwanci
Amfani API;Domin maganin masu fama da ciwon nono

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

www.ruifuchem.com

388082-78-8 - Aikace-aikace:

Lapatinib Ditosylate Monohydrate (CAS: 388082-78-8) shine gishiri ditosylateSaukewa: CAS231277-92-2, wani roba, quinazoline mai aiki da baki tare da yuwuwar aikin antineoplastic.Yana sake toshe phosphorylation na epidermal girma factor receptor (EGFR), ErbB2, da Erk-1 da-2 da AKT kinases;Hakanan yana hana matakan furotin na cyclin D a cikin layin ƙwayoyin ƙwayar cuta na ɗan adam da xenografts.EGFR da ErbB2 sun kasance cikin haɓakar nau'ikan ƙari daban-daban.An ƙaddamar da shi don kula da ci-gaba ko metastatic HER2 (ErbB2) tabbataccen ciwon nono a cikin matan da suka karɓi maganin farko.GlaxoSmithKline ne ya gano kuma ya haɓaka maganin.

Ku rubuta sakonku anan ku aiko mana